Can Patients Receiving Opioid Maintenance Therapy Safely Drive? A Systematic Review of Epidemiological and Experimental Studies on Driving Ability With a Focus on Concomitant Methadone or Buprenorphine Administration

Traffic Injury Prevention

Volumn 14, Issue 1, 2013, Pages 26-38

  Strand, Maren Cecilie ^a   Fjeld, Bente ^a   Arnestad, Marianne ^a   Mørland, Jørg ^a  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

accident risk; buprenorphine; driving; maintenance; methadone; performance

Indexed keywords

BUPRENORPHINE; METHADONE; NARCOTIC ANALGESIC AGENT;

ARTICLE; CAR DRIVING; DRUG EFFECT; HUMAN; OPIATE SUBSTITUTION TREATMENT; PSYCHOLOGICAL ASPECT; PSYCHOMOTOR PERFORMANCE; RISK ASSESSMENT; STATISTICS; TRAFFIC ACCIDENT;

ACCIDENTS, TRAFFIC; ANALGESICS, OPIOID; AUTOMOBILE DRIVING; BUPRENORPHINE; HUMANS; METHADONE; OPIATE SUBSTITUTION TREATMENT; PSYCHOMOTOR PERFORMANCE; RISK ASSESSMENT;

EID: 84871882516     PISSN: 15389588     EISSN: 1538957X     Source Type: Journal    
DOI: 10.1080/15389588.2012.689451     Document Type: Article

References (89)

1. EU directive on driving licences. Council Directive 91/439/EEC of 29 July 1991 on driving licences. Available at: http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=CONSLEG:1991L0439:20080718:EN:PDF. Accessed November 26, 2012.
2. Methadone fact sheet, U.S. Office of National Drug Control Policy. 2000. Available at: http://www.webcitation.org/5yZieaMIE. Accessed May 10, 2011.
3. DRUID project. State of the Art on Driver Rehabilitation: Literature Analysis & Provider Survey. 2008. Available at: http://www.webcitation.org/5ymK2CYzH. Accessed May 18, 2011.
4. Appel, P W. 1982. Sustained attention in methadone patients. Int J Addict., 17: 1313-1327.
5. Appel, P W and Gordon, N B. 1976. Digit-symbol performance in methadone-treated ex-heroin addicts. Am J Psychiatry, 133: 1337-1340.
6. Babst, D V, Newman, S, Gordon, N B and Warner, A. 1973. Driving records of methadone maintenance patients in New York State. J Drug Iss., 3: 285-292.
7. Baewert, A, Gombas, WSchindler, S D. 2007. Influence of peak and trough levels of opioid maintenance therapy on driving aptitude. Eur Addict Res., 13: 127-135.
8. Bernard, J P, Morland, J, Krogh, M and Khiabani, H Z. 2009. Methadone and impairment in apprehended drivers. Addiction., 104: 457-464.
9. Bernard, J P, Opdal, M S, Karinen, R, Morland, J and Khiabani, H Z. 2007. Relationship between methadone and EDDP (2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine) in urine samples from Norwegian prisons. Eur J Clin Pharmacol., 63: 777-782.
10. Blomberg, R D and Preusser, D F. 1974. Narcotic use and driving behavior. Accid Anal Prev., 6: 23-32.
11. Boyer, JL. 2009. The Study of Cognitive Performance in Buprenorphine Treated Opioid Dependent Individuals: A Repeated Measurement Approach, Capella University. Dissertation. Available at: http://www.docstoc.com/docs/47110834/The-study-of-cognitive-performance-in-buprenorphine-treated-opioid-dependent-individuals-A-repeated-measurement-approach. Accessed November 25, 2012.
12. Bramness, J G, Skurtveit, S, Mørland, J and Engeland, A. 2012. An increased risk of motor vehicle accidents after prescription of methadone. Addiction, 107(5): 967-972
13. Chawarski, M C, Schottenfeld, R S, O'Connor, P G and Pakes, J. 1999. Plasma concentrations of buprenorphine 24 to 72 hours after dosing. Drug Alcohol Depend., 55: 157-163.
14. Collins, G B and McAllister, M S. 2007. Buprenorphine maintenance: a new treatment for opioid dependence. Cleve Clin J Med., 74: 514-520.
15. Curran, H V, Kleckham, J, Bearn, J, Strang, J and Wanigaratne, S. 2001. Effects of methadone on cognition, mood and craving in detoxifying opiate addicts: a dose-response study. Psychopharmacology (Berl)., 154: 153-160.
16. Darke, S, Sims, J, McDonald, S and Wickes, W. 2000. Cognitive impairment among methadone maintenance patients. Addiction., 95: 687-695.
17. Davis, P E, Liddiard, H and McMillan, T M. 2002. Neuropsychological deficits and opiate abuse. Drug Alcohol Depend., 67: 105-108.
18. Dittert, S, Naber, D and Soyka, M. 1999. [Methadone substitution therapy and driving. Results of an experimental study]. (Article in German.). Nervenarzt., 70: 457-462.
19. Drummer, O H, Gerostamoulos, JBatziris, H. 2004. The involvement of drugs in drivers of motor vehicles killed in Australian road traffic crashes. Accid Anal Prev., 36: 239-248.
20. Eap, C B, Buclin, T and Baumann, P. 2002. Interindividual variability of the clinical pharmacokinetics of methadone: implications for the treatment of opioid dependence. Clin Pharmacokinet., 41: 1153-1193.
21. Engeland, A, Skurtveit, S and Morland, J. 2007. Risk of road traffic accidents associated with the prescription of drugs: a registry-based cohort study. Ann Epidemiol., 17: 597-602.
22. Ersche, K D, Fletcher, P CRoiser, J P. 2006. Differences in orbitofrontal activation during decision-making between methadone-maintained opiate users, heroin users and healthy volunteers. Psychopharmacology (Berl)., 188: 364-373.
23. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Drug use, impaired driving and traffic accidents. 2008. Available at: http://www.webcitation.org/6CT8Uib9S. Accessed November 26, 2012.
24. Fishbain, D A, Cutler, R B, Rosomoff, H L and Rosomoff, R S. 2003. Are opioid-dependent/tolerant patients impaired in driving-related skills? A structured evidence-based review. J Pain Symptom Manage., 25: 559-577.
25. Fredheim, O M, Kaasa, S, Dale, O, Klepstad, P, Landro, N I and Borchgrevink, P C. 2006. Opioid switching from oral slow release morphine to oral methadone may improve pain control in chronic non-malignant pain: a nine-month follow-up study. Palliat Med., 20: 35-41.
26. Gjerde, H, Normann, P TPettersen, B S. 2008. Prevalence of alcohol and drugs among Norwegian motor vehicle drivers: a roadside survey. Accid Anal Prev., 40: 1765-1772.
27. Gordon, N B. 1970. Reaction-times of methadone treated ex-heroin addicts. Psychopharmacologia., 16: 337-344.
28. Grevert, P, Masover, B and Goldstein, A. 1977. Failure of methadone and levomethadyl acetate (levo-alpha-acetylmethadol, LAAM) maintenance to affect memory. Arch Gen Psychiatry., 34: 849-853.
29. Gritz, E R, Shiffman, S MJarvik, M E. 1975. Physiological and psychological effects of methadone in man. Arch Gen Psychiatry., 32: 237-242.
30. Gruber, S A, Tzilos, G KSilveri, M M. 2006. Methadone maintenance improves cognitive performance after two months of treatment. Exp Clin Psychopharmacol., 14: 157-164.
31. Hanks, G W, O'Neill, W M, Simpson, P and Wesnes, K. 1995. The cognitive and psychomotor effects of opioid analgesics. II. A randomized controlled trial of single doses of morphine, lorazepam and placebo in healthy subjects. Eur J Clin Pharmacol., 48: 455-460.
32. Hauri-Bionda, R, Bar, W and Friedrich-Koch, A. 1998. [Driving fitness/driving capacity of patients treated with methadone]. (Article in German). Schweiz Med Wochenschr, 128: 1538-1547.
33. Hill, J L and Zacny, J P. 2000. Comparing the subjective, psychomotor, and physiological effects of intravenous hydromorphone and morphine in healthy volunteers. Psychopharmacology (Berl)., 152: 31-39.
34. Hornung, P W, Poehlke, TH, Sproedt, H and Köhler-Schmidt, H. 1995. Levomethadone-substitution and driving fitness. Sucht., 42: 92-97.
35. Isbell, H and Wikler, A. 1948. Liability of addiction to 6-dimethylamino-4-4-diphenyl-3-heptanone (methadon, amidone or 10820) in man; experimental addiction to methadon. Arch Intern Med (Chic)., 82: 362-392.
36. Jensen, M L, Sjogren, PUpton, R N. 2008. Pharmacokinetic- pharmacodynamic relationships of cognitive and psychomotor effects of intravenous buprenorphine infusion in human volunteers. Basic Clin Pharmacol Toxicol., 103: 94-101.
37. Kagerer, S, Backmund, M, Walcher, S and Soyka, M. 2002. Substitution mit buprenorphin und fahrtauglichkeit-ergebnisse einer experimentellen untersuchung. [Driving performance under maintenance treatment with buprenorphine]. Suchtmed., 4: 17-24.
38. Kelley, D, Welch, R and McKnelley, W. 1978. Methadone maintenance: an assessment of potential fluctuations in behavior between doses. Int J Addict., 13: 1061-1068.
39. Kelly, E, Darke, S and Ross, J. 2004. A review of drug use and driving: epidemiology, impairment, risk factors and risk perceptions. Drug Alcohol Rev., 23: 319-344.
40. Kubitzki, J H. 1997. Driving behaviour and personality in methadone patients. In: Proceedings of the 14th International Conference on Alcohol, Drugs and Traffic Safety.: 391-399.
41. Lenne, M G, Dietze, P, Rumbold, G R, Cvetkovski, S, Redman, J R and Triggs, T J. Comparison of the effects of methadone, LAAM, and buprenorphine in simulated driving performance. Paper presented at the 15th International Conference on Alcohol, Drugs and Traffic Safety, Stockholm, Sweden
42. Lenne, M G, Dietze, P, Rumbold, G R, Redman, J R and Triggs, T J. 2003. The effects of the opioid pharmacotherapies methadone, LAAM and buprenorphine, alone and in combination with alcohol, on simulated driving. Drug Alcohol Depend., 72: 271-278.
43. Leveille, S G, Buchner, D M, Koepsell, T D, McCloskey, L W, Wolf, M E and Wagner, E H. 1994. Psychoactive medications and injurious motor vehicle collisions involving older drivers. Epidemiology., 5: 591-598.
44. Loeber, S, Kniest, A, Diehl, A, Mann, K and Croissant, B. 2008. Neuropsychological functioning of opiate-dependent patients: a nonrandomized comparison of patients preferring either buprenorphine or methadone maintenance treatment. Am J Drug Alcohol Abuse., 34: 584-593.
45. Lyvers, M and Yakimoff, M. 2003. Neuropsychological correlates of opioid dependence and withdrawal. Addict Behav., 28: 605-611.
46. MacDonald, F C, Gough, K J, Nicoll, R A and Dow, R J. 1989. Psychomotor effects of ketorolac in comparison with buprenorphine and diclofenac. Br J Clin Pharmacol., 27: 453-459.
47. Maddux, J F, Williams, T R and Ziegler, J A. 1977. Driving records before and during methadone maintenance. Am J Drug Alcohol Abuse., 4: 91-100.
48. Manner, T, Kanto, J and Salonen, M. 1987. Simple devices in differentiating the effects of buprenorphine and fentanyl in healthy volunteers. Eur J Clin Pharmacol., 31: 673-676.
49. Messinis, L, Lyros, EAndrian, V. 2009. Neuropsychological functioning in buprenorphine maintained patients versus abstinent heroin abusers on naltrexone hydrochloride therapy. Hum Psychopharmacol., 24: 524-531.
50. Mintzer, M Z. 2007. Effects of opioid pharmacotherapy on psychomotor and cognitive performance: a review of human labaratory studies of methadone and buprenorphine. Heroin Addict Relat Clin Probl., 9: 5-24.
51. Mintzer, M Z, Copersino, M L and Stitzer, M L. 2005. Opioid abuse and cognitive performance. Drug Alcohol Depend., 78: 225-230.
52. Mintzer, M Z and Stitzer, M L. 2002. Cognitive impairment in methadone maintenance patients. Drug Alcohol Depend., 67: 41-51.
53. Mørland, J. 2003. Maintenance treatment and car driving. Maintenance treatment of heroin addiction-evidence at the crossroads. Cappelen Akademisk Forlag.,: 254-264.
54. Moskowitz, H and Robinson, C D. 1985. Methadone Maintenance and Tracking Performance, US Washington, DC: Department of Transport.
55. Mura, P, Kintz, PLudes, B. 2003. Comparison of the prevalence of alcohol, cannabis and other drugs between 900 injured drivers and 900 control subjects: results of a French collaborative study. Forensic Sci Int., 133: 79-85.
56. Orriols, L. 2010. Health-related factors and road safety: influence of medicine use (the CESIR-A Study). Available at: www.theses.fr/2010BOR21723/document. Accessed November 25, 2012.
57. Orriols, L, Salmi, L RPhilip, P. 2009. The impact of medicinal drugs on traffic safety: a systematic review of epidemiological studies. Pharmacoepidemiol Drug Saf., 18: 647-658.
58. Pirastu, R, Fais, RMessina, M. 2006. Impaired decision-making in opiate-dependent subjects: effect of pharmacological therapies. Drug Alcohol Depend., 83: 163-168.
59. Preston, K L, Bigelow, G E and Liebson, I A. 1988. Buprenorphine and naloxone alone and in combination in opioid-dependent humans. Psychopharmacology (Berl)., 94: 484-490.
60. Prosser, J, Cohen, L J, Steinfeld, M, Eisenberg, D, London, E D and Galynker, I I. 2006. Neuropsychological functioning in opiate-dependent subjects receiving and following methadone maintenance treatment. Drug Alcohol Depend., 84: 240-247.
61. Prosser, J, London, E D and Galynker, I I. 2009. Sustained attention in patients receiving and abstinent following methadone maintenance treatment for opiate dependence: performance and neuroimaging results. Drug Alcohol Depend., 104: 228-240.
62. Rapeli, P, Fabritius, C, Alho, H, Salaspuro, M, Wahlbeck, K and Kalska, H. 2007. Methadone vs. buprenorphine/naloxone during early opioid substitution treatment: a naturalistic comparison of cognitive performance relative to healthy controls. BMC Clin Pharmacol., 7: 5
63. Ray, W A, Thapa, P B and Shorr, R I. 1993. Medications and the older driver. Clin Geriatr Med., 9: 413-438.
64. Robinson, C D and Moskowitz, H. 1985. Methadone Maintenence and Aspects of Skilled Performance, 1145-1157. Washington, DC: US Department of Transport.
65. Rothenberg, S, Schottenfeld, S, Gross, K and Selkoe, D. 1980. Specific oculomotor deficit after acute methadone. I. Saccadic eye movements. Psychopharmacology (Berl)., 67: 221-227.
66. Rothenberg, S, Schottenfeld, S, Meyer, R E, Krauss, B and Gross, K. 1977. Performance differences between addicts and non-addicts. Psychopharmacology (Berl)., 52: 299-306.
67. Rothenberg, S, Schottenfeld, S, Selkoe, D and Gross, K. 1980. Specific oculomotor deficit after acute methadone. II. Smooth pursuit eye movements. Psychopharmacology (Berl)., 67: 229-234.
68. Rotheram-Fuller, E, Shoptaw, S, Berman, S M and London, E D. 2004. Impaired performance in a test of decision-making by opiate-dependent tobacco smokers. Drug Alcohol Depend., 73: 79-86.
69. Saarialho-Kere, U, Mattila, M J, Paloheimo, M and Seppala, T. 1987. Psychomotor, respiratory and neuroendocrinological effects of buprenorphine and amitriptyline in healthy volunteers. Eur J Clin Pharmacol., 33: 139-146.
70. Schindler, S D, Ortner, R, Peternell, A, Eder, H, Opgenoorth, E and Fischer, G. 2004. Maintenance therapy with synthetic opioids and driving aptitude. Eur Addict Res., 10: 80-87.
71. Singhal, A, Tripathi, B M, Pal, H R, Jena, R and Jain, R. 2008. Effect of buprenorphine on psychomotor functions in patients on buprenorphine maintenance. J Opioid Manag., 4: 41-47.
72. Soyka, M, Hock, B, Kagerer, S, Lehnert, R, Limmer, C and Kuefner, H. 2005. Less impairment on one portion of a driving-relevant psychomotor battery in buprenorphine-maintained than in methadone-maintained patients: results of a randomized clinical trial. J Clin Psychopharmacol., 25: 490-493.
73. Soyka, M, Lieb, MKagerer, S. 2008. Cognitive functioning during methadone and buprenorphine treatment: results of a randomized clinical trial. J Clin Psychopharmacol., 28: 699-703.
74. Specka, M, Finkbeiner, T, Lodemann, E, Leifert, K, Kluwig, J and Gastpar, M. 2000. Cognitive-motor performance of methadone-maintained patients. Eur Addict Res., 6: 8-19.
75. Staak, M, Berghaus, G, Glazinski, R, Hoher, K, Joo, S and Friedel, B. 1993. [Empirical studies of automobile driving fitness of patients treated with methadone-substitution]. Blutalkohol., 30: 321-333. (Article in German.)
76. Stout, P R and Farrell, L J. 2003. Opioids-effects on human performance and behavior. Forensic Sci Rev., 15: 29-59.
77. Strain, E C, Preston, K L, Liebson, I A and Bigelow, G E. 1992. Acute effects of buprenorphine, hydromorphone and naloxone in methadone-maintained volunteers. J Pharmacol Exp Ther., 261: 985-993.
78. Strain, E C, Preston, K L, Liebson, I A and Bigelow, G E. 1995. Buprenorphine effects in methadone-maintained volunteers: effects at two hours after methadone. J Pharmacol Exp Ther., 272: 628-638.
79. Strain, E C, Walsh, S L, Preston, K L, Liebson, I A and Bigelow, G E. 1997. The effects of buprenorphine in buprenorphine-maintained volunteers. Psychopharmacology (Berl)., 129: 329-338.
80. Strand, M C, Fjeld, B, Arnestad, M and Mørland, J. 2011. Psychomotor relevant performance after administration of opioids, narcoanalgesics and hallucinogens. Available at Available at: http://www.druid-project.eu/cln_031/nn_107548/Druid/EN/deliverales-list/downloads/Deliverable__1__1__2__C,templateId=raw,property=publicationFile.pdf/Deliverable_1_1_2_C.pdf. Accessed November 25, 2012.
81. Verdejo, A, Toribio, I, Orozco, C, Puente, K L and Perez-Garcia, M. 2005. Neuropsychological functioning in methadone maintenance patients versus abstinent heroin abusers. Drug Alcohol Depend., 78: 283-288.
82. Walker, D J and Zacny, J P. 1998. Subjective, psychomotor, and analgesic effects of oral codeine and morphine in healthy volunteers. Psychopharmacology (Berl)., 140: 191-201.
83. Walker, D J and Zacny, J P. 1999. Subjective, psychomotor, and physiological effects of cumulative doses of opioid mu agonists in healthy volunteers. J Pharmacol Exp Ther., 289: 1454-1464.
84. Walsh, J M, Verstraete, A G, Huestis, M A and Morland, J. 2008. Guidelines for research on drugged driving. Addiction., 103: 1258-1268.
85. Walsh, S L, June, H L, Schuh, K J, Preston, K L, Bigelow, G E and Stitzer, M L. 1995. Effects of buprenorphine and methadone in methadone-maintained subjects. Psychopharmacology (Berl)., 119: 268-276.
86. Zacny, J P, Conley, K and Galinkin, J. 1997. Comparing the subjective, psychomotor and physiological effects of intravenous buprenorphine and morphine in healthy volunteers. J Pharmacol Exp Ther., 282: 1187-1197.
87. Zacny, J P and James, P. 1995. A review of the effects of opioids on psychomotor and cognitive functioning in humans. Exp Clin Psychopharmacol., 3: 432-466.
88. Zacny, J P, Lichtor, J L, Flemming, D, Coalson, D W and Thompson, W K. 1994. A dose-response analysis of the subjective, psychomotor and physiological effects of intravenous morphine in healthy volunteers. J Pharmacol Exp Ther., 268: 1-9.
89. Zacny, J P, Lichtor, J L, Thapar, P, Coalson, D W, Flemming, D and Thompson, W K. 1994. Comparing the subjective, psychomotor and physiological effects of intravenous butorphanol and morphine in healthy volunteers. J Pharmacol Exp Ther., 270: 579-588.